Sammy Elmariah, MD, MPH, FACC, FAHA
Adjunct Assistant Professor, Medicine
Biography
Dr. Elmariah graduated from the University of Pennsylvania School of Medicine and completed his internal medicine residency training at the Hospital of the University of Pennsylvania. He subsequently served as Chief Medical Resident at Lankenau Hospital. Dr. Elmariah completed his fellowship in cardiovascular medicine at the Mount Sinai Hospital in New York where he also served as Chief Fellow. While a fellow, he also completed a Masters in Public Health at the Harvard School of Public Health. Dr. Elmariah completed further fellowship training in interventional cardiology and structural heart disease at the Massachusetts General Hospital.
His clinical interest is in the management of valvular heart disease, coronary artery disease, and adult congenital heart disease. He performs transcatheter valve replacement, percutaneous coronary interventions (stents), and transcatheter closure of patent foramen ovale (PFO) and atrial septal defects (ASD).
Dr. Elmariah has a specific research interest in valvular heart disease. In addition to ongoing clinical investigation of valve calcification and the progression of aortic stenosis, Dr. Elmariah is evaluating the impact of transcatheter aortic valve replacement on myocardial metabolism and myocardial remodeling. Dr. Elmariah is an MGH Heart Center Hassenfeld Research Scholar and has been awarded the Jeremiah Stamler Distinguished Young Investigator Award and an American College of Cardiology Young Investigator Award.
Other Positions
- VA Boston Healthcare System
Education
- University of Pennsylvania School of Medicine, MD
- Harvard School of Public Health, MPH
- Emory University, BS
Publications
- Published on 11/27/2024
Reddy KP, Shultz K, Eberly LA, Khatana SAM, Fanaroff AC, Kumbhani DJ, Elmariah S, Fiorilli P, Herrmann H, Desai ND, Atluri P, Szeto WY, McCarthy F, Cohen DJ, Groeneveld PW, Giri J, Nathan AS. Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population. Am Heart J. 2024 Nov 27; 281:59-70. PMID: 39613171.
Read at: PubMed - Published on 11/18/2024
Shimoda T, Ueyama H, Miyamoto Y, Watanabe A, Gotanda H, Kolte D, Latib A, Kaneko T, Zajarias A, Elmariah S, Takayama H, Tsugawa Y, Kuno T. Comparison of Transcatheter versus Surgical Tricuspid Repair among Patients with Tricuspid Regurgitation: Two-Year Results. Circ Cardiovasc Interv. 2024 Nov 18. PMID: 39556351.
Read at: PubMed - Published on 10/28/2024
Singh N, Cohen DJ, Shah MA, Kosinski AS, Brothers L, Vemulapalli S, Elmariah S. Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights. JACC Cardiovasc Interv. 2024 Oct 28; 17(20):2337-2349. PMID: 39477637.
Read at: PubMed - Published on 10/22/2024
Van Mieghem NM, Elmariah S, Spitzer E, Pibarot P, Nazif TM, Bax JJ, Hahn RT, Popma A, Ben-Yehuda O, Kallel F, Redfors B, Chuang ML, Alu MC, Lindeboom W, Kolte D, Zahr FE, Kodali SK, Strote JA, Hermanides RS, Cohen DJ, Tijssen JGP, Leon MB. Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD. J Am Coll Cardiol. 2024 Oct 22. PMID: 39480381.
Read at: PubMed - Published on 10/1/2024
Kolte D, Elmariah S. Real-World Patient Eligibility for Transcatheter Tricuspid Valve Interventions: Translating Trials to Clinical Practice. J Card Fail. 2024 Oct; 30(10):1273-1274. PMID: 39389737.
Read at: PubMed - Published on 9/22/2024
Spanos M, Gokulnath P, Li G, Hutchins E, Meechoovet B, Sheng Q, Chatterjee E, Sharma R, Carnel-Amar N, Lin C, Azzam C, Ghaeli I, Amancherla KV, Victorino JF, Garcia-Mansfield K, Pfeffer R, Sahu P, Lindman BR, Elmariah S, Gamazon ER, Betti MJ, Bledsoe X, Lance ML, Absi T, Su YR, Do N, Contreras MG, Varrias D, Kladas M, Radulovic M, Tsiachris D, Spanos A, Tsioufis K, Ellinor PT, Tucker NR, Januzzi JL, Pirrotte P, Jovanovic-Talisman T, Van Keuren-Jensen K, Shah R, Das S. Cardiomyocyte-derived circulating extracellular vesicles allow a non-invasive liquid biopsy of myocardium in health and disease. medRxiv. 2024 Sep 22. PMID: 39371135.
Read at: PubMed - Published on 8/26/2024
Zahr F, Elmariah S, Vemulapalli S, Kodali SK, Hahn RT, Anderson AS, Eleid MF, Davidson CJ, Sharma RP, O'Neill WW, Bethea B, Thourani VH, Chakravarty T, Gupta A, Makkar RR. Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves. JACC Cardiovasc Interv. 2024 Aug 26; 17(16):1916-1931. PMID: 39197990.
Read at: PubMed - Published on 7/29/2024
Madanat L, Jabri A, Hanson ID, Khalili H, Rodés-Cabau J, Pilgrim T, Okuno T, Elmariah S, Pibarot P, Villablanca P, Abbas AE. Obesity Paradox in Transcatheter Aortic Valve Replacement. Curr Cardiol Rep. 2024 Sep; 26(9):1005-1009. PMID: 39073506.
Read at: PubMed - Published on 7/16/2024
Russo MJ, Elmariah S, Kaneko T, Daniels DV, Makkar RR, Chikermane SG, Thompson C, Benuzillo J, Clancy S, Pawlikowski A, Lawrence S, Luck J. Machine Learning Identification of Modifiable Predictors of Patient Outcomes After Transcatheter Aortic Valve Replacement. JACC Adv. 2024 Aug; 3(8):101116. PMID: 39108421.
Read at: PubMed - Published on 6/29/2024
Abou-Karam R, Tanguturi V, Cheng F, Elmariah S. Electronic physician notification to facilitate the recognition and management of severe aortic stenosis: Rationale, design, and methods of the randomized controlled DETECT AS trial. Am Heart J. 2024 Oct; 276:39-48. PMID: 38950668.
Read at: PubMed
View 180 more publications: View full profile at BUMC